Predictors for hemorrhagic transformation and cerebral edema in stroke patients with first-pass complete recanalization.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 27 11 2023
pubmed: 20 6 2023
entrez: 20 6 2023
Statut: ppublish

Résumé

Predictors of radiological complications attributable to reperfusion injury remain unknown when baseline setting is optimal for endovascular treatment and procedural setting is the best in stroke patients with large vessel occlusion (LVO). To identify clinical and radiological/procedural predictors for hemorrhagic transformation (HT) and cerebral edema (CED) at 24 hr in patients obtaining complete recanalization in one pass of thrombectomy for ischemic stroke ⩽ 6 h from symptom onset with intra-cranial anterior circulation LVO and ASPECTS ⩾ 6. We conducted a cohort study on prospectively collected data from 1400 patients enrolled in the Italian Registry of Endovascular Treatment in Acute Stroke. HT was reported in 248 (18%) patients and early CED was reported in 260 (19.2%) patients. In the logistic regression model including predictors from a first model with clinical variables and from a second model with radiological/procedural variables, diabetes mellitus (odds ratio (OR) = 1.832, 95% confidence interval (CI) = 1.201-2.795), higher National Institutes of Health Stroke Scale (NIHSS) (OR = 1.076, 95% CI = 1.044-1.110), lower Alberta Stroke Program Early CT (ASPECTS) (OR = 0.815, 95% CI = 0.694-0.957), and longer onset-to-groin time (OR = 1.005, 95% CI = 1.002-1.007) were predictors of HT, whereas general anesthesia was inversely associated with HT (OR = 0.540, 95% CI = 0.355-0.820). Higher NIHSS (OR = 1.049, 95% CI = 1.021-1.077), lower ASPECTS (OR = 0.700, 95% CI = 0.613-0.801), intravenous thrombolysis (OR = 1.464, 95% CI = 1.061-2.020), longer onset-to-groin time (OR = 1.002, 95% CI = 1.001-1.005), and longer procedure time (OR = 1.009, 95% CI = 1.004-1.015) were predictors of early CED. After repeating a fourth logistic regression model including also good collaterals, the same variables remained predictors for HT and/or early CED, except diabetes mellitus and thrombolysis, while good collaterals were inversely associated with early CED (OR = 0.385, 95% CI = 0.248-0.599). Higher NIHSS, lower ASPECTS, and longer onset-to-groin time were predictors for both HT and early CED. General anesthesia and good collaterals were inversely associated with HT and early CED, respectively. Longer procedure time was predictor of early CED.

Sections du résumé

BACKGROUND UNASSIGNED
Predictors of radiological complications attributable to reperfusion injury remain unknown when baseline setting is optimal for endovascular treatment and procedural setting is the best in stroke patients with large vessel occlusion (LVO).
AIMS UNASSIGNED
To identify clinical and radiological/procedural predictors for hemorrhagic transformation (HT) and cerebral edema (CED) at 24 hr in patients obtaining complete recanalization in one pass of thrombectomy for ischemic stroke ⩽ 6 h from symptom onset with intra-cranial anterior circulation LVO and ASPECTS ⩾ 6.
METHODS UNASSIGNED
We conducted a cohort study on prospectively collected data from 1400 patients enrolled in the Italian Registry of Endovascular Treatment in Acute Stroke.
RESULTS UNASSIGNED
HT was reported in 248 (18%) patients and early CED was reported in 260 (19.2%) patients. In the logistic regression model including predictors from a first model with clinical variables and from a second model with radiological/procedural variables, diabetes mellitus (odds ratio (OR) = 1.832, 95% confidence interval (CI) = 1.201-2.795), higher National Institutes of Health Stroke Scale (NIHSS) (OR = 1.076, 95% CI = 1.044-1.110), lower Alberta Stroke Program Early CT (ASPECTS) (OR = 0.815, 95% CI = 0.694-0.957), and longer onset-to-groin time (OR = 1.005, 95% CI = 1.002-1.007) were predictors of HT, whereas general anesthesia was inversely associated with HT (OR = 0.540, 95% CI = 0.355-0.820). Higher NIHSS (OR = 1.049, 95% CI = 1.021-1.077), lower ASPECTS (OR = 0.700, 95% CI = 0.613-0.801), intravenous thrombolysis (OR = 1.464, 95% CI = 1.061-2.020), longer onset-to-groin time (OR = 1.002, 95% CI = 1.001-1.005), and longer procedure time (OR = 1.009, 95% CI = 1.004-1.015) were predictors of early CED. After repeating a fourth logistic regression model including also good collaterals, the same variables remained predictors for HT and/or early CED, except diabetes mellitus and thrombolysis, while good collaterals were inversely associated with early CED (OR = 0.385, 95% CI = 0.248-0.599).
CONCLUSIONS UNASSIGNED
Higher NIHSS, lower ASPECTS, and longer onset-to-groin time were predictors for both HT and early CED. General anesthesia and good collaterals were inversely associated with HT and early CED, respectively. Longer procedure time was predictor of early CED.

Identifiants

pubmed: 37337362
doi: 10.1177/17474930231185690
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1238-1246

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Manuel Cappellari received consultancy or advisory board fees or speaker’s honoraria from Boehringer Ingelheim, Pfizer/Bristol Meyer Squibb, and Daiichi Sankyo. Andrea Zini received consulting fees from Boehringer-Ingelheim consulting fees from Boehringer-Ingelheim, Alexion and CLS Behring. All other authors report no conflicts of interest. The other authors report no conflicts.

Auteurs

Manuel Cappellari (M)

Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Giovanni Pracucci (G)

University of Florence, Florence, Italy.

Valentina Saia (V)

S. Corona Hospital, Pietra Ligure, Italy.

Fabrizio Sallustio (F)

Ospedale dei Castelli-ASL6, Roma, Italy.

Ilaria Casetta (I)

University Hospital Arcispedale S. Anna, Ferrara, Italy.

Enrico Fainardi (E)

Ospedale Universitario Careggi, Firenze, Italy.

Francesco Capasso (F)

Ospedale Universitario Careggi, Firenze, Italy.

Patrizia Nencini (P)

Ospedale Universitario Careggi, Firenze, Italy.

Stefano Vallone (S)

Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.

Guido Bigliardi (G)

Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.

Andrea Saletti (A)

University Hospital Arcispedale S. Anna, Ferrara, Italy.

Alessandro De Vito (A)

University Hospital Arcispedale S. Anna, Ferrara, Italy.

Maria Ruggiero (M)

AUSL Romagna Ospedale Bufalini, Cesena, Italy.

Marco Longoni (M)

AUSL Romagna Ospedale Bufalini, Cesena, Italy.

Vittorio Semeraro (V)

SS. Annunziata Hospital, Taranto, Italy.

Giovanni Boero (G)

SS. Annunziata Hospital, Taranto, Italy.

Umberto Silvagni (U)

Azienda Ospedaliera di Cosenza, Cosenza, Italy.

Furio Stancati (F)

Azienda Ospedaliera di Cosenza, Cosenza, Italy.

Elvis Lafe (E)

Policlinico IRCCS San Matteo, Pavia, Italy.

Federico Mazzacane (F)

IRCCS Fondazione Mondino, Pavia, Italy.

Sandra Bracco (S)

Ospedale S. Maria delle Scotte-University Hospital, Siena, Italy.

Rossana Tassi (R)

Ospedale S. Maria delle Scotte-University Hospital, Siena, Italy.

Simone Comelli (S)

ARNAS G. Brotzu, Cagliari, Italy.

Maurizio Melis (M)

ARNAS G. Brotzu, Cagliari, Italy.

Daniele Romano (D)

AOU San Giovanni di Dio e Ruggi di Aragona, Salerno, Italy.

Rosa Napoletano (R)

AOU San Giovanni di Dio e Ruggi di Aragona, Salerno, Italy.

Roberto Menozzi (R)

Ospedale Universitario, Parma, Italy.

Umberto Scoditti (U)

Ospedale Universitario, Parma, Italy.

Luigi Chiumarulo (L)

AOU Consorziale Policlinico, Bari, Italy.

Marco Petruzzellis (M)

AOU Consorziale Policlinico, Bari, Italy.

Sergio Lucio Vinci (SL)

University of Messina, Messina, Italy.

Ludovica Ferraù (L)

University of Messina, Messina, Italy.

Francesco Taglialatela (F)

IRCCS Istituto di Scienze Neurologiche di Bologna, Bologna, Italy.

Andrea Zini (A)

IRCCS Istituto di Scienze Neurologiche di Bologna, Bologna, Italy.

Antioco Sanna (A)

S. Corona Hospital, Pietra Ligure, Italy.

Tiziana Tassinari (T)

S. Corona Hospital, Pietra Ligure, Italy.

Marta Iacobucci (M)

Sapienza University of Rome, Rome, Italy.

Ettore Nicolini (E)

Sapienza University of Rome, Rome, Italy.

Mauro Bergui (M)

Città della Salute e della Scienza-Molinette, Torino, Italy.

Paolo Cerrato (P)

Città della Salute e della Scienza-Molinette, Torino, Italy.

Andrea Giorgianni (A)

ASST Sette Laghi Varese-Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Lucia Princiotta Cariddi (L)

ASST Sette Laghi Varese-Ospedale di Circolo e Fondazione Macchi, Varese, Italy.

Pietro Amistà (P)

Ospedale S. Maria Misericordia, Rovigo, Italy.

Monia Russo (M)

Ospedale S. Maria Misericordia, Rovigo, Italy.

Ivan Gallesio (I)

AO SS Antonio e Biagio e C. Arrigo, Alessandria, Italy.

Federica Sepe (F)

AO SS Antonio e Biagio e C. Arrigo, Alessandria, Italy.

Alessio Comai (A)

Ospedale Provinciale di Bolzano, Bolzano, Italy.

Enrica Franchini (E)

Ospedale Provinciale di Bolzano, Bolzano, Italy.

Pietro Filauri (P)

PO Avezzano (AQ), Italy.

Berardino Orlandi (B)

PO Avezzano (AQ), Italy.

Michele Besana (M)

Ospedale di Cremona, ASST Cremona, Cremona, Italy.

Alessia Giossi (A)

Ospedale di Cremona, ASST Cremona, Cremona, Italy.

Guido Andrea Lazzarotti (GA)

Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Giovanni Orlandi (G)

Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Davide Castellano (D)

Ospedale San Giovanni Bosco, Torino, Italy.

Andrea Naldi (A)

Ospedale San Giovanni Bosco, Torino, Italy.

Mauro Plebani (M)

Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Cecilia Zivelonghi (C)

Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.

Paolo Invernizzi (P)

Istituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy.

Salvatore Mangiafico (S)

Sapienza University of Rome, Rome, Italy.
IRCCS Neuromed, Pozzilli, Italy.
Tor Vergata University, Rome, Italy.
S. Andrea Hospital, Rome, Italy.

Danilo Toni (D)

Sapienza University of Rome, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH